NCT Number: NCT02349308
Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter
The purpose of this study is to demonstrate the stability of blood flow with the CentrosFLO catheter, during intermittent dialysis over a period of 6 months after placement.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
Angiocare, Tucson, Arizona, United States
About this study
The CentrosFLO™ Tunneled Dialysis Catheter is a 15F dual-lumen, double-D shaped catheter similar to other "split tip" catheters in the market: outflow ("arterial") and return ("venous") lumens that separate, a subcutaneous Dacron® cuff, extension sets with clamps and caps, and construction from Carbothane® material. The CentrosFLO™ catheter contains two small pressure-relief holes near the tips.
The main difference of the CentrosFLO catheter is in the design of the tip. Current "split tip" catheters have two free ends that diverge, but are each essentially straight segments. In the CentrosFLO catheter the arterial lumen bends in an arc back towards the venous lumen, and the venous lumen bends towards the arterial lumen. As a result, the catheter has two curved surfaces that will rest against the vena cava wall to automatically "center" the catheter within the vein. The contact points of the catheter against the vena cava wall should be smaller and more disperse than with current straight-tip or split catheters. The following drawing demonstrates the design of the catheter, showing the current recommendation that the arterial port always be to the left.
The goal of the study is to demonstrate the stability of blood flow with the CentrosFLO catheter, during intermittent dialysis over a period of 6 months after placement. The investigators plan to enroll 10 patients in the study.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Adult patients who are initiating or continuing in-center intermittent hemodialysis who are scheduled to receive a tunneled dialysis catheter in the right or left internal jugular vein
- The patients may have had a prior tunneled catheter for dialysis in the right IJ site.
- Patients will be expected to need use of the catheter for more than 45 days
Exclusion criteria
- Patients in whom the catheter is planned to be placed into the same site as an existing catheter, by over-the-wire catheter exchange
- Patients unable to give informed consent
Treatment and study plan
Primary outcomes
-
Primary Endpoint: Stability of hydraulic resistance measured as normalized arterial pressure in mmHg/mL/min by dialysis flow meter weekly for up to six months
Time frame: 1.5 years
Stability of hydraulic resistance measured as normalized arterial pressure in mmHg/mL/min by dialysis flow meter weekly for up to six months
Secondary outcomes
-
Secondary Endpoint: Incidence of patency failure defined as blood flow rate below 300 mL/min or removal of catheter for failure of flow at any time during the study.
Time frame: 1.5 years
Incidence of patency failure defined as blood flow rate below 300 mL/min or removal of catheter for failure of flow at any time during the study.
Sponsors and collaborators
Lead sponsor
Merit Medical Systems, Inc.
Industry
Registry information
Official study title
Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis
Acronym: MCENPS
Important dates
- Study start
- 2013
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Jan 28, 2015
- Registry last updated
- Sep 3, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Brief Mindfulness Intervention for Patients at a Free Acute Care Clinic
NCT07025161
Neurologic Manifestations, Pain
Orlando, Florida, United States
View Trial DetailsLow vs Medium Pressure Pneumoperitoneum
NCT04949659
Appendicitis, Appendicitis Acute
Zurich, Canton of Zurich, Switzerland
View Trial DetailsPectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
NCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsPain Neuroscience Education for Middle School Students
NCT06869369
Behavior, Motor Activity
Kütahya, Turkey (Türkiye)
View Trial Details